SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (288)1/1/2003 6:51:01 PM
From: Londo  Read Replies (2) of 897
 
The only problem with this move is that VXGN is on the UPC11830 list, so I wouldn't know how you would mirror this move in reality (spreads on options are insanely high).

That said, VXGN will trade at around 3 bucks a share by the end of 2003. The announcement that that AIDSVAX is a bust should tank the stock 60% in a single day, and then it'll hover around 80% of their cash value I figure. I'm really surprised they haven't done a secondary offering while their stock is up in the 20's. Oh, and the 3 dollars a share assumes that they're going to raise another $50-$60M shortly in that secondary.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News